GMP Compliance · FDA Inspection Readiness · 2026 6 GMP Compliance Gaps Regulators Always Find — And How to Close Them Before Your Next Inspection In 2026, over 60% of critical inspection findings trace back to weak pharmaceutical quality systems, not the product. Here is what FDA inspectors look for, and how to stay ahead
Process Validation in 2026: Meeting FDA and EMA Expectations “Process validation is not a one-time event. It is a lifecycle commitment that links science, risk management, and regulatory compliance from Day 1 through commercial manufacture.” In 2026, pharmaceutical manufacturers face a regulatory environment that is more data-driven, more transparent, and more demanding than ever before.
Process Validation in 2026: Meeting FDA and EMA Expectations Read More »
How Hayat Pharmaceuticals Consulting Helps Biotech Startups Building a biotech startup is one of the most ambitious things a scientist or entrepreneur can do. You have a molecule with potential. You have a vision for how it could change patients’ lives. But between that vision and a commercially approved drug lies one of the most
How Hayat Pharmaceuticals Consulting Helps Biotech Startups Navigate FDA Approval Read More »
Meet amazing people behind our support We have highly trained staff with International and National Experience Dr Umar Hayat CEO / Founder Dr Umar Hayat CEO / Founder Umar Hayat, Ph.D. is a founder of Trials 360 and has more than two decades of experience in pharmaceutical development, manufacturing and supply chain. He held senior
Meet amazing people behind our support We are a dynamic team of pharmaceutical development experts and regulatory strategists. HPC is a global team of technical experts and regulatory experts who provide end-to-end drug development solutions to our clients, including early research and commercial launch. Our expertise enables clients to navigate complexity, conquer scientific challenges, and